Zobrazeno 1 - 4
of 4
pro vyhledávání: '"BRAF class I/II/III mutants"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eunhye Ju, Injae Shin, Eunhye Jeon, SeongShick Ryu, Wonjeong Cho, Namkyoung Kim, Ji Won Lee, Taebo Sim, Young Hoon Kim
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 7
International Journal of Molecular Sciences, Vol 22, Iss 3783, p 3783 (2021)
Volume 22
Issue 7
International Journal of Molecular Sciences, Vol 22, Iss 3783, p 3783 (2021)
Melanoma accounts for the majority of skin cancer deaths. About 50% of all melanomas are associated with BRAF mutations. BRAF mutations are classified into three classes with regard to dependency on RAF dimerization and RAS signaling. The most freque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4c897919cea02f8f40eb93625fd919
http://europepmc.org/articles/PMC8038755
http://europepmc.org/articles/PMC8038755
Autor:
Dragomir, Mihaela1,2 (AUTHOR) cerasela.jardan@umfcd.ro, Călugăru, Onda-Tabita2 (AUTHOR) calugaru.onda@gmail.com, Popescu, Bogdan3 (AUTHOR) bogdan.popescu2@drd.umfcd.ro, Jardan, Cerasela2,3 (AUTHOR) silviaaposteanu@gmail.com, Jardan, Dumitru4 (AUTHOR) d.jardan@gmail.com, Popescu, Monica2 (AUTHOR) sorinabadelita@gmail.com, Aposteanu, Silvia2 (AUTHOR) gabi.nedelcu12@gmail.com, Bădeliță, Sorina2 (AUTHOR) serbannicucatalin@yahoo.com, Nedelcu, Gabriela2 (AUTHOR) delia.popa@umfcd.ro, Șerban, Cătălin2 (AUTHOR) daniel.coriu@umfcd.ro, Popa, Codruța2,3 (AUTHOR), Vassu-Dimov, Tatiana1 (AUTHOR) tatiana.vassu@bio.unibuc.ro, Coriu, Daniel2,3 (AUTHOR)
Publikováno v:
Cancers. Jan2024, Vol. 16 Issue 2, p358. 15p.
Autor:
Hanrahan AJ; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen Z; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Physiology, Biophysics & Systems Biology, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY, USA., Rosen N; Molecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, Cornell University, New York, NY, USA., Solit DB; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.; Weill Cornell Medical College, Cornell University, New York, NY, USA. solitd@mskcc.org.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2024 Mar; Vol. 21 (3), pp. 224-247. Date of Electronic Publication: 2024 Jan 26.